Primary central nervous system lymphoma and atypical glioblastoma: Multiparametric differentiation by using diffusion-, perfusion-, and susceptibility-weighted MR imaging

Radiology

Volumn 272, Issue 3, 2014, Pages 843-850

  Kickingereder, Philipp ^a   Wiestler, Benedikt ^a,b   Sahm, Felix ^a,b   Heiland, Sabine ^a   Roethke, Matthias ^b   Schlemmer, Heinz Peter ^b   Wick, Wolfgang ^a,b   Bendszus, Martin ^a   Radbruch, Alexander ^a,b  

^a UNIVERSITY OF HEIDELBERG   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; AGED, 80 AND OVER; BRAIN NEOPLASMS; CELL DIFFERENTIATION; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; GLIOBLASTOMA; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; LYMPHOMA; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MULTIMODAL IMAGING; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 84906855037     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.14132740     Document Type: Article

References (32)

1. Stupp R, Mason WP, van den Bent MJ, et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005;352(10):987-996. (Pubitemid 40349501)
2. Schlegel U. Primary CNS lymphoma. Ther Adv Neurol Disord 2009;2(2):93-104.
3. Haldorsen IS, Espeland A, Larsson EM. Central nervous system lymphoma: characteristic findings on traditional and advanced imaging. AJNR Am J Neuroradiol 2011;32(6):984-992.
4. Peters S, Knöß N, Wodarg F, Cnyrim C, Jansen O. Glioblastomas vs. lymphomas: more diagnostic certainty by using susceptibility-weighted imaging (SWI). Rofo 2012;184(8):713-718.
5. Doskaliyev A, Yamasaki F, Ohtaki M, et al. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T. Eur J Radiol 2012;81(2):339-344.
6. Toh CH, Wei KC, Chang CN, Ng SH, Wong HF. Differentiation of primary central nervous system lymphomas and glioblastomas: comparisons of diagnostic performance of dynamic susceptibility contrast-enhanced perfusion MR imaging without and with contrast-leakage correction. AJNR Am J Neuroradiol 2013;34(6):1145-1149.
7. Wang S, Kim S, Chawla S, et al. Differentiation between glioblastomas, solitary brain metastases, and primary cerebral lymphomas using diffusion tensor and dynamic susceptibility contrast-enhanced MR imaging. AJNR Am J Neuroradiol 2011;32(3):507-514.
8. Radbruch A, Wiestler B, Kramp L, et al. Differentiation of glioblastoma and primary CNS lymphomas using susceptibility weighted imaging. Eur J Radiol 2013;82(3):552-556.
9. Lee HY, Kim HS, Park JW, Baek HJ, Kim SJ, Choi CG. Atypical imaging features of Epstein-Barr virus-positive primary central nervous system lymphomas in patients without AIDS. AJNR Am J Neuroradiol 2013;34(8):1562-1567.
10. Kitai R, Matsuda K, Adachi E, et al. Epstein-Barr virus-associated primary central nervous system lymphoma in the Japanese population. Neurol Med Chir (Tokyo) 2010;50(2):114-118.
11. Kim HS, Jahng GH, Ryu CW, Kim SY. Added value and diagnostic performance of intratumoral susceptibility signals in the differential diagnosis of solitary enhancing brain lesions: preliminary study. AJNR Am J Neuroradiol 2009;30(8):1574-1579.
12. Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33(1):159-174. (Pubitemid 8054849)
13. Blasel S, Jurcoane A, Bähr O, Weise L, Harter PN, Hattingen E. MR perfusion in and around the contrast-enhancement of primary CNS lymphomas. J Neurooncol 2013;114(1):127-134.
14. Liao W, Liu Y, Wang X, et al. Differentiation of primary central nervous system lymphoma and high-grade glioma with dynamic susceptibility contrast-enhanced perfusion magnetic resonance imaging. Acta Radiol 2009;50(2):217-225.
15. Hakyemez B, Erdogan C, Bolca N, Yildirim N, Gokalp G, Parlak M. Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imaging 2006;24(4):817-824. (Pubitemid 44549984)
16. Rollin N, Guyotat J, Streichenberger N, Honnorat J, Tran Minh VA, Cotton F. Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intra-axial brain tumors. Neuroradiology 2006;48(3):150-159. (Pubitemid 43380227)
17. Calli C, Kitis O, Yunten N, Yurtseven T, Islekel S, Akalin T. Perfusion and diffusion MR imaging in enhancing malignant cerebral tumors. Eur J Radiol 2006;58(3):394-403. (Pubitemid 43729064)
18. Hartmann M, Heiland S, Harting I, et al. Distinguishing of primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003;338(2):119-122. (Pubitemid 36140152)
19. Bhagavathi S, Wilson JD. Primary central nervous system lymphoma. Arch Pathol Lab Med 2008;132(11):1830-1834.
20. Hardee ME, Zagzag D. Mechanisms of glioma-associated neovascularization. Am J Pathol 2012;181(4):1126-1141.
21. Paulson ES, Schmainda KM. Comparison of dynamic susceptibility-weighted contrast-enhanced MR methods: recommendations for measuring blood volume in brain tumors. Radiology 2008;249(2):601-613.
22. Boxerman JL, Prah DE, Paulson ES, Machan JT, Bedekar D, Schmainda KM. The Role of preload and leakage correction in gadolinium-based cerebral blood volume estimation determined by comparison with MION as a criterion standard. AJNR Am J Neuroradiol 2012;33(6):1081-1087.
23. Makino K, Hirai T, Nakamura H, et al. Does adding FDG-PET to MRI improve the differentiation between primary cerebral lymphoma and glioblastoma? Observer performance study. Ann Nucl Med 2011;25(6):432-438.
24. Yamasaki F, Kurisu K, Satoh K, et al. Apparent diffusion coefficient of human brain tumors at MR imaging. Radiology 2005;235(3):985-991. (Pubitemid 40695898)
25. 18F-fluorodeoxyglucose positron emission tomography. Neuroradiology 2013;55(2):135-143.
26. Horger M, Fenchel M, Nägele T, et al. Water diffusivity: comparison of primary CNS lymphoma and astrocytic tumor infiltrating the corpus callosum. AJR Am J Roentgenol 2009;193(5):1384-1387.
27. Server A, Kulle B, Maehlen J, et al. Quantitative apparent diffusion coefficients in the characterization of brain tumors and associated peritumoral edema. Acta Radiol 2009;50(6):682-689.
28. Toh CH, Castillo M, Wong AM, et al. Primary cerebral lymphoma and glioblastoma multiforme: differences in diffusion characteristics evaluated with diffusion tensor imaging. AJNR Am J Neuroradiol 2008;29(3):471-475. (Pubitemid 351424059)
29. Matsushima N, Maeda M, Umino M, Suzawa N, Yamada T, Takeda K. Relation between FDG uptake and apparent diffusion coefficients in glioma and malignant lymphoma. Ann Nucl Med 2012;26(3):262-271.
30. Guo AC, Cummings TJ, Dash RC, Provenzale JM. Lymphomas and high-grade astrocytomas: comparison of water diffusibility and histologic characteristics. Radiology 2002;224(1):177-183. (Pubitemid 34680392)
31. Dietrich O, Heiland S, Sartor K. Noise correction for the exact determination of apparent diffusion coefficients at low SNR. Magn Reson Med 2001;45(3):448-453. (Pubitemid 32173272)
32. Deistung A, Schweser F, Wiestler B, et al. Quantitative susceptibility mapping differentiates between blood depositions and calcifications in patients with glioblastoma. PLoS ONE 2013;8(3):e57924.